| mitoguazone | <chemical> 1,1-[(methylethanediylidene)dinitrilo]diguanidine. Antineoplastic agent effective against myelogenous leukaemia in experimental animals. Also acts as an inhibitor of animal s-adenosylmethionine decarboxylase. Pharmacological action: antineoplastic agent, enzyme inhibitors. Chemical name: Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis- (12 Dec 1998) |
|---|---|
| mitolactol | <chemical> 1,6-dibromo-1,6-dideoxygalactitol. Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs. Pharmacological action: antineoplastic agent, alkylating. Chemical name: Galactitol, 1,6-dibromo-1,6-dideoxy- (12 Dec 1998) |
| mitome | <biology> The denser part of the protoplasm of a cell. Origin: Gr. A thread. Source: Websters Dictionary (01 Mar 1998) |
| mitomycin | Antibiotic produced by Streptomyces caespitosus, variants of which are designated mitomycin A, mitomycin B, etc.; mitomycin C is an antineoplastic agent and a bacteriocide; inhibits DNA synthesis. (05 Mar 2000) |
| mitomycin C | <drug> Aziridine antibiotic isolated from Streptomyces caespitosus. Inhibits DNA synthesis by cross linking the strands. (18 Nov 1997) |
| mitomycins | <chemical> A group of methylazirinopyrroloindolediones obtained from certain streptomyces strains. They are very toxic antibiotics used as antineoplastic agent in some solid tumours. Porfiromycin and mitomycin c are the most useful members of the group. Pharmacological action: antibiotics, antineoplastic. (12 Dec 1998) |
| mitoplast | <cell biology> Isolated mitochondria without their outer membranes. They have finger like processes and retain the capacity for oxidative phosphorylation. (18 Nov 1997) |
| mitoribosome | <cell biology> Mitochondrial ribosomes, these more closely resemble prokaryotic ribosomes than cytoplasmic ribosomes of the cells in which they are found, though they are even smaller and have fewer proteins than bacterial ribosomes. Origin: Gr. Soma = body (18 Nov 1997) |
| mitosis | <cell biology> A method of indirect division of a cell, consisting of a complex of various processes, by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes characteristic of the somatic cells of the species. Mitosis, the process by which the body grows and replaces cells, is divided into four phases. 1. Prophase: formation of paired chromosomes, disappearance of nuclear membrane, appearance of the achromatic spindle, formation of polar bodies. 2. Metaphase: arrangement of chromosomes in the equatorial plane of the central spindle to form the monaster. Chromosomes separate into exactly similar halves. 3. Anaphase: the two groups of daughter chromosomes separate and move along the fibres of the central spindle, each toward one of the asters, forming the diaster. 4. Telophase: the daughter chromosomes resolve themselves into a reticulum and the daughter nuclei are formed, the cytoplasm divides, forming two complete daughter cells. NOTE: the term mitosis is used interchangeably with cell division, but strictly speaking it refers to nuclear division, whereas cytokinesis refers to division of the cytoplasm. In some cells, as in many fungi and the fertilized eggs of many insects, nuclear division occurs within the cell unaccompanied by division of the cytoplasm and formation of daughter cells. (13 Nov 1997) |
| mitotane | <chemical> 1-chloro-2-(2,2-dichloro)-1-(4-chlorophenyl)ethylbenzene. A derivative of the insecticide ddd that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumours and causes CNS damage, but no bone marrow depression. Pharmacological action: antineoplastic agent, hormonal. Chemical name: Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)- (12 Dec 1998) |
| mitotic | Pertaining to mitosis. (12 Dec 1998) |
| mitotic apparatus | See: mitosis, spindle fibre. (18 Nov 1997) |
| mitotic cell selection | A drug-free procedure for the selection of mitotic cells from an exponentially growing monolayer. (09 Oct 1997) |
| mitotic cycle | <cell biology, molecular biology> The sequence of events between mitotic divisions. The cycle is conventionally divided into G0, G1, (G standing for gap), S (synthesis phase during which the DNA is replicated), G2 and M (mitosis). Cells that will not divide again are considered to be in G0 and the transition from G0 to G1 is thought to commit the cell to completing the cycle and dividing. (26 Mar 1998) |
| mitotic death | <cell biology> Cells fatally damaged by ionising radiation may not die until the next mitosis, at which point the radiation damage to the DNA becomes evident, particularly when there is fragmentation of chromosomes. (18 Nov 1997) |
Synonyms : Mitochondria Size, Mitochondria Volume, Mitochondrial Volume, Mitochondria Sizes, Mitochondria Volumes, Mitochondrial Sizes, Mitochondrial Volumes, Size, Mitochondria, Size, Mitochondrial, Sizes, Mitochondria, Sizes, Mitochondrial, Volume, Mitochondria
Synonyms : Mitochondrial Swellings, Swelling, Mitochondrial, Swellings, Mitochondrial
Synonyms : ERK2 Brain Kinase PK40, MAPK1 Mitogen-Activated Protein Kinase, MAPK2 Mitogen-Activated Protein Kinase, p40 Mitogen-Activated Protein Kinase, p41 Mitogen-Activated Protein Kinase, p42(Mapk), p42(Mapk) Kinase, Extracellular Signal Regulated Kinase 2
Synonyms : JNK3 Mitogen Activated Protein Kinase, MAP Kinase p49(3F12), MAPK10 Mitogen-Activated Protein Kinase, Mitogen Activated Protein Kinase p49(3F12), Stress-Activated Protein Kinase JNK3, c-jun Kinase 3, c-jun N-Terminal Kinase 3, p49 3F12 Kinase, p54-SAPK(beta)
Synonyms : MAPK11 Mitogen-Activated Protein Kinase, Mitogen-Activated Protein Kinase Eleven, SAP Kinase-2, SAPK2, SAPK2b, Stress-Activated Protein Kinase 2, Stress-Activated Protein Kinase 2b, p38(beta) MAP Kinase, p38beta MAP Kinase, Kinase, p38beta MAP, SAP Kinase 2
| mitochondrial body |
a fused colony of mitochondria found in the spermatids of insects.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| mitochondrial cristae |
cris
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| mitochondrial encephalomyopathy |
any of a group of diseases characterized by abnormal mitochondrial function with involvement of the central nervous system and skeletal muscle and, in most cases, lactic acidosis. Diseases in this group, which includes subacute necrotizing encephalomyelitis, Leber's hereditary optic neuropathy, MELAS syndrome, and MERRF syndrome, may also be classified as mitochondrial myopathies or mitochondrial encephalopathies.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| mitochondrial encephalopathy |
any of numerous encephalopathies associated with mitochondrial abnormalities, such as cytochrome-c oxidase deficiency.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| mitral facies |
mitrotricuspid facies, the appearance of the face of some patients with mitral stenosis of long duration, marked by rosy, flushed cheeks and dilated capillaries.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| MIT | foetid Eurasian weed having round flat pods |
|---|---|
| MIT | ancient king of Pontus who expanded his kingdom by defeating the Romans but was later driven out by Pompey (132-63 BC) |
| MIT | ancient king of Pontus who expanded his kingdom by defeating the Romans but was later driven out by Pompey (132-63 BC) |
| MIT | ancient king of Pontus who expanded his kingdom by defeating the Romans but was later driven out by Pompey (132-63 BC) |
| MIT | can be alleviated |
| MIT | make less severe or harsh |
| MIT | lessen or to try to lessen the seriousness or extent of |
| MIT | made less severe or intense |
| MIT | (law) a circumstance that does not exonerate a person but which reduces the penalty associated with the offense |
| MIT | to act in such a way as to cause an offense to seem less serious |
| MIT | a partial excuse to mitigate censure |
| MIT | moderating pain or sorrow by making it easier to bear |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|